Browsing: Corporation

McKesson Corporation (NYSE:MCK) has agreed to acquire privately held Precision Medicine Group for approximately $2.25 billion, as the healthcare company continues shifting its portfolio toward higher-growth businesses. Precision Medicine provides clinical research, laboratory testing, and commercialization services to biotechnology and pharmaceutical companies developing and launching new medicines. McKesson plans to integrate the company into its…

Net Profit of NT$219 Million (US$6.94 Million), Up 175.1% Annually; Q2 EPS NT$2.01; Board Approves NT$1.81 per Share Q2 Dividend

NEW YORK, Aug. 26, 2026 /PRNewswire/ — Graviton BioScience Corporation, a privately held, clinical-stage biotechnology company, announced the publication of peer-reviewed data from a multicenter Phase Ib/II multi-dose, open-label clinical trial evaluating the safety, tolerability, and efficacy of GV101 in patients with moderate to severe chronic Graft versus Host Disease (cGvHD). The data, published in…

This is a paid press release. Contact the press release distributor directly with any inquiries.

CAMBRIDGE, Mass. and NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) —  OHB Pediatrics Ltd. d/b/a Oak Hill Bio, a clinical-stage rare disease therapeutics company, and RACC, a special purpose acquisition company (SPAC) sponsored by RA Capital Management, today announced that they have entered into a definitive business combination agreement. In connection with consummation of the…

Actus Nutrition today announced that it has achieved Certified B Corporation™ status, joining a global community of businesses that value social and environmental performance, accountability, and transparency. For more than 80 years, Actus Nutrition has upcycled dairy-based raw materials into high-value nutrition ingredients used by customers around the world. Earning B Corp certification reflects the…

This is a paid press release. Contact the press release distributor directly with any inquiries.